Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenomatous Polyposis Coli 1

Interventions

pembrolizumab 1273 Specimen Handling 871 Carboplatin 832 Magnetic Resonance Spectroscopy 808 Cyclophosphamide 803 Cisplatin 729 Nivolumab 659 Paclitaxel 631 Radiotherapy 574 Gemcitabine 572 Biopsy 529 Bevacizumab 476 Dexamethasone 440 fludarabine 407 Docetaxel 378 venetoclax 370 Oxaliplatin 365 Capecitabine 358 Fluorouracil 355 atezolizumab 344 durvalumab 334 Rituximab 333 Doxorubicin 317 Radiosurgery 309 Pemetrexed 306 Drug Therapy 303 Ipilimumab 294 Standard of Care 293 Etoposide 285 Radiation 281

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thiamine × 1 year × Clear all

NCT06649825 2026-04-24

VitB1; FAP

Shanghai Zhongshan Hospital

Phase NA Enrolling by invitation

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡